Erin Miller, Marketing Director
FOR IMMEDIATE RELEASE
Ganeden and Pathway International Announce Exclusive Distribution Partnership
Pathway International to serve as exclusive Australian and New Zealand distributor for GanedenBC30 probiotic
CLEVELAND (Feb. 3, 2010) – Ganeden, Inc., makers of the patented probiotic strain GanedenBC30, today announced a partnership with Pathway International Pty Ltd to exclusively distribute GanedenBC30 in all Australian and New Zealand markets.
The partnership will provide growth opportunities for Ganeden through increased distribution channels and access to an exclusive international supply chain network of leading manufacturers in Australia and New Zealand.
“Partnering with Pathway International is an important step in achieving our global expansion goals for 2010,” said Andrew Lefkowitz, Ganeden president and CEO. “We are confident that Pathway International’s proven track record in successfully distributing innovative health and wellness ingredients will help our probiotic reach consumers in these markets looking to support their digestive health and immunity with probiotic-enhanced food, beverage and supplement products.”
Since 2008, GanedenBC30 has been incorporated in more than 40 products widely distributed throughout North America. Due to the unique ability of the shelf-stable probiotic to survive harsh manufacturing processes, it can be incorporated into a variety of products ranging from frozen yogurt to baked goods.
“We look forward to a long-term relationship with Ganeden through which we can help introduce GanedenBC30 to new markets and manufacturers interested in innovative functional ingredients,” said Wayne Coote, managing director of Pathway International.
Ganeden is at the forefront of probiotic research and product development with an extensive library of published studies and more than 100 patents for probiotic technologies in the food, beverage, animal health, sports nutrition and personal care ingredients markets. Ganeden is best known for GanedenBC30 (Bacillus coagulans GBI-30, 6086), its patented, FDA GRAS, non-GMO, highly stable probiotic ingredient. Ganeden's newest ingredient, Bonicel, is the first science-backed, probiotic-derived, personal care ingredient shown to dramatically reduce signs of aging. For more information about Ganeden and licensing opportunities visit GanedenProbiotics.com.
About Pathway International Pty Ltd.:
Pathway is the exclusive distributor in Australia and New Zealand for leading suppliers of high quality and innovative ingredients that add value to the health care and nutrition industries. For more information visit www.Pathway.net.au